Lithospermidin B
Lithospermidin B is a derivative of Shikonin (HY-N0822) and an inhibitor of SARS-CoV-2 main protease (Mpro). Lithospermidin B can be used for the research of COVID-19.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 83415-79-6
- Formel: C21H24O7
- Molecular Weight:388.41
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Lithospermidin B exhibits favorable drug-likeness properties, including low predicted cardiac toxicity, high oral absorption, and suitable human serum albumin binding[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 83415-79-6
-
Molecular Weight 388.41
-
Formel C21H24O7
-
SMILES
O=C1C=C(C(/C=C/C(C)(C)O)OC(CC(C)C)=O)C(C2=C1C(O)=CC=C2O)=O
-
Structure Classification
-
Initial Source
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)